{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:19:08Z","timestamp":1780499948628,"version":"3.54.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologie"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00120-026-02835-2","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T05:51:14Z","timestamp":1779774674000},"page":"669-677","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Individuelle operative Therapie des benignen Prostatasyndroms","Individualized surgical treatment of benign prostate syndrome"],"prefix":"10.1007","volume":"65","author":[{"given":"H. C.","family":"von Knobloch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rodler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Weische","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Bach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"2835_CR1","unstructured":"S2e- Leitlinie- Diagnostik und Therapie des Benignen Prostatasyndrom (BPS), Langversion 5.0- Stand Februar 2023"},{"key":"2835_CR2","doi-asserted-by":"crossref","unstructured":"Alexander, C.E., et\u00a0al., Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction. Cochrane Database Syst Rev, 2019. 12: p. CD009629.","DOI":"10.1002\/14651858.CD009629.pub4"},{"key":"2835_CR3","doi-asserted-by":"publisher","unstructured":"Wei JT, Dauw CA, Brodsky CN. Lower Urinary Tract Symptoms in Men. JAMA. 2025;:2836455. https:\/\/doi.org\/10.1001\/jama.2025.7045.","DOI":"10.1001\/jama.2025.7045"},{"key":"2835_CR4","doi-asserted-by":"crossref","unstructured":"Madersbacher, S.\u00a0and M.\u00a0Marberger, Is transurethral resection of the prostate still justified? BJU Int, 1999. 83(3): p.\u00a0227-37.","DOI":"10.1046\/j.1464-410x.1999.00908.x"},{"key":"2835_CR5","doi-asserted-by":"crossref","unstructured":"Gilfrich, C., et\u00a0al., Surgical Reintervention Rates after Invasive Treatment for Lower Urinary Tract Symptoms due to Benign Prostatic Syndrome: A\u00a0Comparative Study of More than 43,000 Patients with Long-Term Followup. J\u00a0Urol, 2021. 205(3): p.\u00a0855-863.","DOI":"10.1097\/JU.0000000000001463"},{"key":"2835_CR6","doi-asserted-by":"crossref","unstructured":"Dotzauer, R., et\u00a0al., Robot-assisted simple prostatectomy versus open simple prostatectomy: a\u00a0single-center comparison. World J Urol, 2021. 39(1): p.\u00a0149-156.","DOI":"10.1007\/s00345-020-03168-1"},{"key":"2835_CR7","doi-asserted-by":"crossref","unstructured":"Gratzke, C., et\u00a0al., Complications and early postoperative outcome after open prostatectomy in patients with benign prostatic enlargement: results of a\u00a0prospective multicenter study. J\u00a0Urol, 2007. 177(4): p.\u00a01419-22.","DOI":"10.1016\/j.juro.2006.11.062"},{"key":"2835_CR8","unstructured":"Cornu JN, Gacci M, Hashim H, Herrmann TRW, Malde S, Netsch C, De Nunzio C, Rieken M, Sakalakis V, Tutolo M. Eau Guidelines on non-neurogenic male lower urinary tract symptoms (LUTS). European Association of Urology 2025"},{"key":"2835_CR9","doi-asserted-by":"crossref","unstructured":"Amparore, D., et\u00a0al., 3\u2011Year results following treatment with the second generation of the temporary implantable nitinol device in men with LUTS secondary to benign prostatic obstruction. Prostate Cancer Prostatic Dis, 2020.","DOI":"10.1038\/s41391-020-00281-5"},{"key":"2835_CR10","doi-asserted-by":"crossref","unstructured":"Chughtai, B., et\u00a0al., The iTind Temporarily Implanted Nitinol Device for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A\u00a0Multicenter, Randomized, Controlled Trial. Urology, 2020.","DOI":"10.1016\/j.urology.2020.12.022"},{"key":"2835_CR11","doi-asserted-by":"crossref","unstructured":"Perera, M., et\u00a0al., Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: a\u00a0systematic review and metaanalysis. Eur Urol, 2015. 67(4): p.\u00a0704-13.","DOI":"10.1016\/j.eururo.2014.10.031"},{"key":"2835_CR12","doi-asserted-by":"crossref","unstructured":"Miller, L.E., et\u00a0al., Surgical Reintervention Rate after Prostatic Urethral Lift: Systematic Review and Meta-Analysis Involving over 2,000 Patients. J\u00a0Urol, 2020. 204(5): p.\u00a01019-1026.","DOI":"10.1097\/JU.0000000000001132"},{"key":"2835_CR13","doi-asserted-by":"crossref","unstructured":"Chin, P.T., et\u00a0al., Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology, 2012. 79(1): p.\u00a05-11.","DOI":"10.1016\/j.urology.2011.10.021"},{"key":"2835_CR14","doi-asserted-by":"crossref","unstructured":"McVary, K.T., T.\u00a0Rogers, and C.G.\u00a0Roehrborn, Rez\u016bm Water Vapor Thermal Therapy for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: 4\u2011Year Results From Randomized Controlled Study. Urology, 2019. 126: p.\u00a0171-179.","DOI":"10.1016\/j.urology.2018.12.041"},{"key":"2835_CR15","doi-asserted-by":"publisher","unstructured":"Bausch K, Zahiti L, Schrutt M, et\u00a0al. Water Vapor Thermal Therapy of Lower Urinary Tract Symptoms Due to Benign Prostatic Obstruction: Efficacy and Safety Analysis of a\u00a0Real-World Cohort of 211 Patients. World Journal of Urology. 2023;41(6):1605-1612. https:\/\/doi.org\/10.1007\/s00345-023-04395-y","DOI":"10.1007\/s00345-023-04395-y"},{"key":"2835_CR16","doi-asserted-by":"crossref","unstructured":"McVary, K.T. et\u00a0al., Final 5\u2011Year Outcomes of the Multicenter Randomized Sham-Controlled Trial of a\u00a0Water Vapor Thermal Therapy for Treatment of Moderate to Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia, 2021, Journal od Urology","DOI":"10.1097\/JU.0000000000001778"},{"key":"2835_CR17","doi-asserted-by":"crossref","unstructured":"Jung JH, M.K., Borofsky M, Young S, Golzarian J, Reddy B, Shin TY, Kim MH, Narayan V, Dahm P Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia. . 2020. Cochrane Database of Systematic Reviews 2020, Issue 12. Art. No.: CD012867.","DOI":"10.1002\/14651858.CD012867.pub2"},{"key":"2835_CR18","doi-asserted-by":"crossref","unstructured":"McVary KT, Rogers T, Mahon J, Gupta NK. Is sexual function better preserved after water vapor thermal therapy or medical therapy for lower urinary tract symptoms due to benign prostatic hyperplasia? 2018, J\u00a0Sex Med.","DOI":"10.1016\/j.jsxm.2018.10.006"},{"key":"2835_CR19","doi-asserted-by":"crossref","unstructured":"Abt, D., et\u00a0al., Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial. BMJ, 2018. 361: p. k2338.","DOI":"10.1136\/bmj.k2338"},{"key":"2835_CR20","unstructured":"Andre Uflacker et\u00a0al. Meta-Analysis of Prostatic Artery Embolization for Benign Prostatic HyperplasiaAffiliations Expand, 2016, J\u00a0Vasc Interv Radiol PMID: 27742235"},{"key":"2835_CR21","doi-asserted-by":"publisher","unstructured":"Moreira AM, de Assis AM, Carnevale FC, Antunes AA, Srougi M, Cerri GG. A\u00a0Review of Adverse Events Related to Prostatic Artery Embolization for Treatment of Bladder Outlet Obstruction Due to BPH. Cardiovasc Intervent Radiol. 2017 Oct;40(10):1490-1500. https:\/\/doi.org\/10.1007\/s00270-017-1765-3. Epub 2017 Aug 9. PMID: 28795212.","DOI":"10.1007\/s00270-017-1765-3"},{"key":"2835_CR22","doi-asserted-by":"crossref","unstructured":"Pisco, J.M., et\u00a0al., Medium- and Long-Term Outcome of Prostate Artery Embolization for Patients with Benign Prostatic Hyperplasia: Results in 630 Patients. J\u00a0Vasc Interv Radiol, 2016. 27(8): p.\u00a01115-22.","DOI":"10.1016\/j.jvir.2016.04.001"},{"key":"2835_CR23","doi-asserted-by":"crossref","unstructured":"Zumstein, V., et\u00a0al., Prostatic Artery Embolization versus Standard Surgical Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A\u00a0Systematic Review and Meta-analysis. Eur Urol Focus, 2019. 5(6): p.\u00a01091-1100.","DOI":"10.1016\/j.euf.2018.09.005"},{"key":"2835_CR24","doi-asserted-by":"crossref","unstructured":"G. Mullhaupt, L. Hechelhammer, P.A. Diener, et\u00a0al.Ejaculatory disorders after prostatic artery embolization: a reassessment of two prospective clinical trials World J Urol, 38 (2020), pp.\u00a02595-2599","DOI":"10.1007\/s00345-019-03036-7"},{"key":"2835_CR25","doi-asserted-by":"crossref","unstructured":"Pereira-Correia, J.A., de Moraes Sousa, K.D., Santos, J.B.P., de Morais Perp\u00e9tuo, D., Lopes-da-Silva, L.F., Krambeck, R.L., Muller, V.J.F. and Vaz, F.P., 2012. GreenLight HPS\u2122 120\u2011W laser vaporization vs transurethral resection of the prostate (\u3008\u202f60\u202fmL): a\u00a02-year randomized double-blind prospective urodynamic investigation. BJU international, 110(8), pp.1184-1189.","DOI":"10.1111\/j.1464-410X.2011.10878.x"},{"key":"2835_CR26","doi-asserted-by":"publisher","unstructured":"de la Rosette J, Elhilali M, Naito S, Unal D, Razvi H, Liatsikos E, Bachmann A, Tubaro A, Alivizatos G, Mak SK, Badlani G, Eltahawy E, Wong C, Telich Vidal M, Te A, d\u2019Ancona F, Arum CJ, Gutierrez J; Clinical Research Office of the Endourological Society Global GreenLight Laser Study Group. Clinical Research Office of the Endourological Society Global GreenLight Laser Study: Outcomes from a\u00a0contemporary series of 713 patients. Int J Urol. 2015 Dec;22(12):1124-30. https:\/\/doi.org\/10.1111\/iju.12906. Epub 2015 Aug 25. PMID: 26307430.","DOI":"10.1111\/iju.12906"},{"key":"2835_CR27","doi-asserted-by":"publisher","unstructured":"Gild P, Vetterlein MW, Daoud I, Ludwig TA, Soave A, Marks P, Chun FK, Ahyai S, Dahlem R, Fisch M, Rink M, Meyer CP, Becker A. Which Men Do or Do Not Achieve Long-Term Symptom Relief After Holmium Laser Enucleation of the Prostate (HoLEP): 11 Years of HoLEP Experience. J\u00a0Endourol. 2023 Mar;37(3):316-322. https:\/\/doi.org\/10.1089\/end.2022.0396. Epub 2023 Feb 6. PMID: 36352826.","DOI":"10.1089\/end.2022.0396"},{"key":"2835_CR28","doi-asserted-by":"publisher","unstructured":"Placer J, Salvador C, Planas J, Trilla E, Lorente D, Celma A, L\u00f3pez M\u00c1, Morote J. Effects of holmium laser enucleation of the prostate on sexual function. J\u00a0Endourol. 2015 Mar;29(3):332\u20119. https:\/\/doi.org\/10.1089\/end.2014.0502. Epub 2014 Oct 21. PMID: 25133981.","DOI":"10.1089\/end.2014.0502"},{"key":"2835_CR29","doi-asserted-by":"publisher","unstructured":"Briganti A, Naspro R, Gallina A, Salonia A, Vavassori I, Hurle R, et\u00a0al. Impact on Sexual Function of Holmium Laser Enucleation Versus Transurethral Resection of the Prostate: Results of a Prospective, 2\u2011Center, Randomized Trial. Journal of Urology [Internet]. 2006 May 1 [cited 2026 Mar 15];175(5):1817\u201321. Available from: https:\/\/doi.org\/10.1016\/S0022-5347(05)00983-3","DOI":"10.1016\/S0022-5347(05)00983-3"},{"key":"2835_CR30","doi-asserted-by":"crossref","unstructured":"Huang Foen Chung, J.W.N.C., et\u00a0al., Prostate volume ultrasonography: The influence of transabdominal versus transrectal approach, device type and operator. European Urology, 2004. 46(3): p.\u00a0352-356.","DOI":"10.1016\/j.eururo.2004.05.002"},{"key":"2835_CR31","doi-asserted-by":"crossref","unstructured":"Hartung, F.O., Kowalewski, K.F., von Hardenberg, J., Worst, T.S., Kriegmair, M.C., Nuhn, P., Herrmann, T.R., Michel, M.S. and Herrmann, J., 2022. Holmium versus thulium laser enucleation of the prostate: a\u00a0systematic review and meta-analysis of randomized controlled trials. European urology focus, 8(2), pp.545-554.","DOI":"10.1016\/j.euf.2021.03.024"},{"key":"2835_CR32","doi-asserted-by":"crossref","unstructured":"Desai, M., Bidair, M., Bhojani, N., Trainer, A., Arther, A., Kramolowsky, E., Doumanian, L., Elterman, D., Kaufman Jr, R.P., Lingeman, J. and Krambeck, A., 2019. WATER II (80\u2013150\u202fmL) procedural outcomes. BJU international, 123(1), pp.106-112.","DOI":"10.1111\/bju.14360"},{"key":"2835_CR33","doi-asserted-by":"crossref","unstructured":"Gilling, P., Barber, N., Bidair, M., Anderson, P., Sutton, M., Aho, T., Kramolowsky, E., Thomas, A., Cowan, B., Kaufman, R.P. and Trainer, A., 2018. WATER: a double-blind, randomized, controlled trial of Aquablation vs transurethral resection of the prostate in benign prostatic hyperplasia. The Journal of urology, 199(5), pp.1252-1261.","DOI":"10.1016\/j.juro.2017.12.065"},{"key":"2835_CR34","doi-asserted-by":"crossref","unstructured":"He, W., Ding, T., Niu, Z., Hao, C., Li, C., Xu, Z., Jing, Y. and Qin, W., 2023. Reoperation after surgical treatment for benign prostatic hyperplasia: a\u00a0systematic review. Frontiers in Endocrinology, 14, p.1287212.","DOI":"10.3389\/fendo.2023.1287212"},{"key":"2835_CR35","doi-asserted-by":"crossref","unstructured":"Plante, M., Gilling, P., Barber, N., Bidair, M., Anderson, P., Sutton, M., Aho, T., Kramolowsky, E., Thomas, A., Cowan, B. and Kaufman Jr, R.P., 2019. Symptom relief and anejaculation after aquablation or transurethral resection of the prostate: subgroup analysis from a\u00a0blinded randomized trial. BJU international, 123(4), pp.651-660.","DOI":"10.1111\/bju.14426"},{"key":"2835_CR36","doi-asserted-by":"crossref","unstructured":"Elterman, D., Bach, T., Rijo, E., Misrai, V., Anderson, P., Zorn, K.C., Bhojani, N., El Hajj, A., Chughtai, B. and Desai, M., 2020. Transfusion rates after 800 Aquablation procedures using various haemostasis methods. BJU international, 125(4), pp.568-572.","DOI":"10.1111\/bju.14990"},{"key":"2835_CR37","doi-asserted-by":"crossref","unstructured":"Porpiglia, F., et\u00a0al., Urethral-sparing Robot-assisted Simple Prostatectomy: An Innovative Technique to Preserve Ejaculatory Function Overcoming the Limitation of the Standard Millin Approach. Eur Urol, 2021. 80(2): p.\u00a0222-233.","DOI":"10.1016\/j.eururo.2020.09.028"}],"container-title":["Die Urologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-026-02835-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00120-026-02835-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-026-02835-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:25:45Z","timestamp":1780496745000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00120-026-02835-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2835"],"URL":"https:\/\/doi.org\/10.1007\/s00120-026-02835-2","relation":{},"ISSN":["2731-7064","2731-7072"],"issn-type":[{"value":"2731-7064","type":"print"},{"value":"2731-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"15 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autorinnen und Autoren sowie die Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"H.C.\u00a0von Knobloch\n                      : A.\u00a0Finanzielle Interessen: H.\u00a0C. von Knobloch gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Angestellter Urologe UKSH Kiel | Mitgliedschaften: DGU, EAU.\n                      T.\u00a0Bach\n                      : A.\u00a0Finanzielle Interessen: T.\u00a0Bach gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellter Urologe UKSH Kiel, Leiter Endourologie.\n                      S.\u00a0Rodler\n                      : A.\u00a0Finanzielle Interessen: S.\u00a0Rodler gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Angestellter Urologe UKSH Kiel | Mitgliedschaften: DGU, EAU.\n                      O.\u00a0Weische\n                      : A.\u00a0Finanzielle Interessen: O.\u00a0Weische gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellter Urologe UKSH Kiel.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autorinnen und Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf\n                      \n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}